Arlo McGinn
Directeur/Membre du Conseil chez Gina Bachauer International Piano Foundation
Profil
Arlo McGinn is a trustee at Gina Bachauer International Piano Foundation.
He previously worked as a director at Immunomic Therapeutics, Inc. and held principal positions at TL Administration Corp.
and MacroMed, Inc. He also served as an associate at the University of Utah.
Dr. McGinn's education includes an undergraduate degree from Brigham Young University in 2002.
Postes actifs de Arlo McGinn
| Sociétés | Poste | Début |
|---|---|---|
| Gina Bachauer International Piano Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Arlo McGinn
| Sociétés | Poste | Fin |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
University of Utah /Venture Capital/
 University of Utah /Venture Capital/ Investment ManagersFinance University of Utah /Venture Capital/ (University Venture) is a private equity/venture capital subsidiary of David Eccles School of Business founded in 2001.The firm is headquartered in Salt Lake City, Utah. | Analyste en capital-investissement | 31/05/2011 |
MacroMed, Inc.
 MacroMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., MacroMed, Inc. develops and manufactures pharmaceutical products. The company is based in West Valley City, UT. The company was founded by Sung Wan Kim. The CEO is Thomas Bergmann. MacroMed was acquired by Protherics Plc on January 04, 2007 for $25 million. | Corporate Officer/Principal | 01/07/2008 |
TL Administration Corp.
 TL Administration Corp. Pharmaceuticals: OtherHealth Technology TL Administration Corp. manufactures and markets vitamins, minerals, and bodybuilding supplements. It also offers weight management products. The company was founded by David Blechman in 1968 and is headquartered in Farmingdale, NY. | Corporate Officer/Principal | 01/03/2006 |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | - |
Formation de Arlo McGinn
| Brigham Young University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
TL Administration Corp.
TL Administration Corp. Pharmaceuticals: OtherHealth Technology TL Administration Corp. manufactures and markets vitamins, minerals, and bodybuilding supplements. It also offers weight management products. The company was founded by David Blechman in 1968 and is headquartered in Farmingdale, NY. | Health Technology |
MacroMed, Inc.
MacroMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., MacroMed, Inc. develops and manufactures pharmaceutical products. The company is based in West Valley City, UT. The company was founded by Sung Wan Kim. The CEO is Thomas Bergmann. MacroMed was acquired by Protherics Plc on January 04, 2007 for $25 million. | Health Technology |
University of Utah /Venture Capital/
University of Utah /Venture Capital/ Investment ManagersFinance University of Utah /Venture Capital/ (University Venture) is a private equity/venture capital subsidiary of David Eccles School of Business founded in 2001.The firm is headquartered in Salt Lake City, Utah. | Finance |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
| Gina Bachauer International Piano Foundation |